logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 11 of 11 Items
Showing 1 - 11 of 11 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Weight gain at 3 months of antiretroviral therapy is strongly associated with survival: evidence from two developing countries

Madec Y, Szumilin E, Genevier C, Ferradini LLF, Balkan S,  et al.
2009-04-27 • AIDS
2009-04-27 • AIDS
BACKGROUND
In developing countries, access to laboratory tests remains limited, and the use of simple tools such as weight to monitor HIV-infected patients treated with antiretrovira...
Journal Article
|
Research

Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial

Piola P, Fogg C, Bajunirwe F, Biraro S, Grandesso F,  et al.
2005-04-23 • Lancet
2005-04-23 • Lancet
BACKGROUND: The six-dose regimen of artemether-lumefantrine is effective and is among combination therapies prioritised to replace antimalarials that no longer work in Africa. However, i...
Journal Article
|
Commentary

Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up

Calmy A, Klement E, Teck R, Berman D, Pecoul B,  et al.
2004-12-03 • AIDS
2004-12-03 • AIDS
Journal Article
|
Research

Prevalence study of yaws in the Democratic Republic of Congo using the lot quality assurance sampling method

Gerstl S, Kiwila G, Dhorda M, Lonlas S, Myatt M,  et al.
2009-07-22 • PLOS One
2009-07-22 • PLOS One
BACKGROUND: Until the 1970s the prevalence of non-venereal trepanomatosis, including yaws, was greatly reduced after worldwide mass treatment. In 2005, cases were again reported in the D...
Journal Article
|
Research

Immunovirological outcomes and resistance patterns at 4 years of antiretroviral therapy use in HIV-infected patients in Cambodia

Pujades-Rodriguez M, Schramm B, Som L, Nerrienet E, Narom P,  et al.
2011-02-01 • Tropical Medicine and International Health
2011-02-01 • Tropical Medicine and International Health
Objectives  To report immunovirological outcomes and resistance patterns in adults treated with triple combination antiretroviral therapy (cART) for 4 years in an HIV programme of Phnom ...
Journal Article
|
Research

Adherence to antiretroviral therapy in patients enrolled in a comprehensive care program in Cambodia: a 24-month follow-up assessment

Spire B, Carrieri P, Sopha P, Protopopescu C, Prak N,  et al.
2008-09-11 • Antiviral therapy
2008-09-11 • Antiviral therapy
BACKGROUND
The long-term maintenance of antiretroviral therapy (ART) remains an important issue, especially in limited-resource settings where additional barriers exist. A cross-sect...
Journal Article
|
Research

Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort

Calmy A, Pinoges LLP, Szumilin E, Zachariah R, Ford NP,  et al.
2006-05-12 • AIDS
2006-05-12 • AIDS
BACKGROUND
The use fixed-dose combination (FDC) is a critical tool in improving HAART. Studies on the effectiveness of combined lamivudine, stavudine and nevirapine (3TC/d4T/NVP) are...
Journal Article
|
Research

Tuberculosis After HAART Initiation in HIV-Positive Patients from Five Countries with a High Tuberculosis Burden

Bonnet MMB, Pinoges LLP, Varaine FFV, Oberhauser BBO, O'Brien DP,  et al.
2006-06-12 • AIDS
2006-06-12 • AIDS
BACKGROUND: HAART reduces tuberculosis (TB) incidence in people living with HIV/AIDS but those starting HAART may develop active TB or subclinical TB may become apparent in the immune re...
Journal Article
|
Research

Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia

Madec Y, Laureillard D, Pinoges LLP, Fernandez MAL, Prak N,  et al.
2007-01-30 • AIDS
2007-01-30 • AIDS
BACKGROUND: HAART efficacy was evaluated in a real-life setting in Phnom Penh (Médecins Sans Frontières programme) among severely immuno-compromised patients. METHODS: Factors associated...
Journal Article
|
Research

Positive Outcomes of HAART at 24 Months in HIV-Infected Patients in Cambodia

Ferradini LLF, Laureillard D, Prak N, Ngeth C, Fernandez MAL,  et al.
2007-11-12 • AIDS
2007-11-12 • AIDS
OBJECTIVES: African and Asian cohort studies have demonstrated the feasibility and efficacy of HAART in resource-poor settings. The long-term virological outcome and clinico-immunologica...
Journal Article
|
Research

Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment

Ferradini LLF, Jeannin A, Pinoges LLP, Izopet J, Odhiambo D,  et al.
2006-04-22 • Lancet
2006-04-22 • Lancet
BACKGROUND: The recording of outcomes from large-scale, simplified HAART (highly active antiretroviral therapy) programmes in sub-Saharan Africa is critical. We aimed to assess the effec...